Designation supports rapid development of pan‑RAS molecular glue

New device classification created for precision optical filter

Autoinjector offers at‑home dosing from start of treatment

European ruling supports development in rare endocrine disorders

Early results show safety, CSF penetration and PK clarity

First participant enrolled in EquilibriX S study

Study shows reversible switch for targeted cytokine delivery

Agency clarifies UK pathway for emerging therapies

Priority review granted for first‑in‑class Tourette therapy

First guidance for a licensed hyperhidrosis treatment